학술논문
LBA92 Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1333-S1334
Subject
Language
ISSN
0923-7534